Invention Grant
- Patent Title: Heteroaryl compounds for kinase inhibition
-
Application No.: US15600023Application Date: 2017-05-19
-
Publication No.: US09796712B2Publication Date: 2017-10-24
- Inventor: Wei-Sheng Huang , Yongjin Gong , Feng Li , Nicholas E. Bencivenga , David C. Dalgarno , Anna Kohlmann , William C. Shakespeare , Ranny M. Thomas , Xiaotian Zhu , Angela V. West , Willmen Youngsaye , Yun Zhang , Tianjun Zhou
- Applicant: Ariad Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Lucy X. Yang; Jonathan P. O'Brien
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D403/14 ; C07D471/04 ; C07D405/12 ; C07F9/6558 ; C07D401/14 ; C07D403/04
Abstract:
Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.
Public/Granted literature
- US20170253594A1 HETEROARYL COMPOUNDS FOR KINASE INHIBITION Public/Granted day:2017-09-07
Information query
IPC分类:
